**Flu hospitalization rates follow strong seasonal patterns, with activity typically minimal during summer months due to reduced virus transmission in warmer weather and lower population mixing after the winter peak.** CDC FluSurv-NET data show weekly rates dropping sharply after May, reaching exactly 0.1 per 100,000 population in Week 21 (ending May 30, 2026) amid overall seasonal decline. By late July and early August (encompassing Week 31), rates historically fall to or below this threshold as influenza circulation approaches its annual nadir. Recent surveillance through mid-2026 confirms no anomalous summer resurgence, with cumulative rates stabilizing and outpatient indicators remaining low. Market-implied odds heavily favor <0.1 (59.6%) over exactly 0.1 (39.0%) or higher (1.3%), reflecting trader assessment of these consistent epidemiological trends and the low likelihood of atypical off-season spikes absent unusual factors like novel variants. Upcoming CDC FluView updates for late July/early August weeks will provide the final observational data for resolution.
基于Polymarket数据的AI实验性摘要。这不是交易建议，也不影响该市场的结算方式。 · 更新于流感住院率2026年第31周？
流感住院率2026年第31周？
>0.1 1.3%
<0.1 0
0.1 0
最新
最新
2026-08-14
<0.1
62%
0.1
39%
>0.1
1%
>0.1 1.3%
<0.1 0
0.1 0
最新
最新
2026-08-14
<0.1
$330 交易量
62%
0.1
$174 交易量
39%
>0.1
$385 交易量
1%
This market will resolve according to the weekly influenza-associated hospitalization rate per 100,000 population for the United States, as reported by CDC FluSurv-NET for the specified week.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
CDC FluView reports the weekly FluSurv-NET hospitalization rate per 100,000 population to one decimal point (e.g., 0.1). Thus, this is the level of precision that will be used when resolving the market.
Note: Only the CDC FluSurv-NET weekly hospitalization rate per 100,000 population for the specified week will qualify, regardless of the cumulative influenza-associated hospitalization rate, estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.**Flu hospitalization rates follow strong seasonal patterns, with activity typically minimal during summer months due to reduced virus transmission in warmer weather and lower population mixing after the winter peak.** CDC FluSurv-NET data show weekly rates dropping sharply after May, reaching exactly 0.1 per 100,000 population in Week 21 (ending May 30, 2026) amid overall seasonal decline. By late July and early August (encompassing Week 31), rates historically fall to or below this threshold as influenza circulation approaches its annual nadir.
Recent surveillance through mid-2026 confirms no anomalous summer resurgence, with cumulative rates stabilizing and outpatient indicators remaining low. Market-implied odds heavily favor <0.1 (59.6%) over exactly 0.1 (39.0%) or higher (1.3%), reflecting trader assessment of these consistent epidemiological trends and the low likelihood of atypical off-season spikes absent unusual factors like novel variants. Upcoming CDC FluView updates for late July/early August weeks will provide the final observational data for resolution.
This market will resolve according to the weekly influenza-associated hospitalization rate per 100,000 population for the United States, as reported by CDC FluSurv-NET for the specified week.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
CDC FluView reports the weekly FluSurv-NET hospitalization rate per 100,000 population to one decimal point (e.g., 0.1). Thus, this is the level of precision that will be used when resolving the market.
Note: Only the CDC FluSurv-NET weekly hospitalization rate per 100,000 population for the specified week will qualify, regardless of the cumulative influenza-associated hospitalization rate, estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
CDC FluView reports the weekly FluSurv-NET hospitalization rate per 100,000 population to one decimal point (e.g., 0.1). Thus, this is the level of precision that will be used when resolving the market.
Note: Only the CDC FluSurv-NET weekly hospitalization rate per 100,000 population for the specified week will qualify, regardless of the cumulative influenza-associated hospitalization rate, estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
市场开放时间： Aug 8, 2026, 12:08 PM ET
交易量
$889结束日期
2026-08-14市场开放时间
Aug 8, 2026, 12:08 PM ETResolver
0x69c47De9D...This market will resolve according to the weekly influenza-associated hospitalization rate per 100,000 population for the United States, as reported by CDC FluSurv-NET for the specified week.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
CDC FluView reports the weekly FluSurv-NET hospitalization rate per 100,000 population to one decimal point (e.g., 0.1). Thus, this is the level of precision that will be used when resolving the market.
Note: Only the CDC FluSurv-NET weekly hospitalization rate per 100,000 population for the specified week will qualify, regardless of the cumulative influenza-associated hospitalization rate, estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.**Flu hospitalization rates follow strong seasonal patterns, with activity typically minimal during summer months due to reduced virus transmission in warmer weather and lower population mixing after the winter peak.** CDC FluSurv-NET data show weekly rates dropping sharply after May, reaching exactly 0.1 per 100,000 population in Week 21 (ending May 30, 2026) amid overall seasonal decline. By late July and early August (encompassing Week 31), rates historically fall to or below this threshold as influenza circulation approaches its annual nadir.
Recent surveillance through mid-2026 confirms no anomalous summer resurgence, with cumulative rates stabilizing and outpatient indicators remaining low. Market-implied odds heavily favor <0.1 (59.6%) over exactly 0.1 (39.0%) or higher (1.3%), reflecting trader assessment of these consistent epidemiological trends and the low likelihood of atypical off-season spikes absent unusual factors like novel variants. Upcoming CDC FluView updates for late July/early August weeks will provide the final observational data for resolution.
This market will resolve according to the weekly influenza-associated hospitalization rate per 100,000 population for the United States, as reported by CDC FluSurv-NET for the specified week.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
CDC FluView reports the weekly FluSurv-NET hospitalization rate per 100,000 population to one decimal point (e.g., 0.1). Thus, this is the level of precision that will be used when resolving the market.
Note: Only the CDC FluSurv-NET weekly hospitalization rate per 100,000 population for the specified week will qualify, regardless of the cumulative influenza-associated hospitalization rate, estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
CDC FluView reports the weekly FluSurv-NET hospitalization rate per 100,000 population to one decimal point (e.g., 0.1). Thus, this is the level of precision that will be used when resolving the market.
Note: Only the CDC FluSurv-NET weekly hospitalization rate per 100,000 population for the specified week will qualify, regardless of the cumulative influenza-associated hospitalization rate, estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
交易量
$889结束日期
2026-08-14市场开放时间
Aug 8, 2026, 12:08 PM ETResolver
0x69c47De9D...**Flu hospitalization rates follow strong seasonal patterns, with activity typically minimal during summer months due to reduced virus transmission in warmer weather and lower population mixing after the winter peak.** CDC FluSurv-NET data show weekly rates dropping sharply after May, reaching exactly 0.1 per 100,000 population in Week 21 (ending May 30, 2026) amid overall seasonal decline. By late July and early August (encompassing Week 31), rates historically fall to or below this threshold as influenza circulation approaches its annual nadir. Recent surveillance through mid-2026 confirms no anomalous summer resurgence, with cumulative rates stabilizing and outpatient indicators remaining low. Market-implied odds heavily favor <0.1 (59.6%) over exactly 0.1 (39.0%) or higher (1.3%), reflecting trader assessment of these consistent epidemiological trends and the low likelihood of atypical off-season spikes absent unusual factors like novel variants. Upcoming CDC FluView updates for late July/early August weeks will provide the final observational data for resolution.
基于Polymarket数据的AI实验性摘要。这不是交易建议，也不影响该市场的结算方式。 · 更新于
警惕外部链接哦。
警惕外部链接哦。
常见问题